Expert Opinion

The future of noncompetes is uncertain, but the current trend is decidedly toward limiting their application.

This decision leaves the door open for other plaintiffs who may bring a similar challenge against the FDA and mifepristone in the future.

"You need to stay up to the minute on developments," said Mark S. Goldstein, a labor and employment lawyer at Reed Smith. "We have to be able to be flexible and pivot quite quickly, with the patchwork of employment laws at the state and local level."

Employers are advised to work closely with labor and employment counsel in evaluating options.

Employers should train supervisors on how to receive and respond to PWFA accommodation requests.

In mid-February, CMS released revised instructions for the highly anticipated third RxDC reports, which encompass the 2023 calendar year and are due…